Sri Lanka on the brink of a crippling medicine shortage

Colombo, April 22 (Daily Mirror) - Sri Lanka is on the brink of a crippling medicine shortage, including essential and life saving medicines, that threatens to paralyze both public and private healthcare sectors, the Sri Lanka Chamber of the Pharmaceutical Industry (SLCPI) warned yesterday.

Issuing an urgent call to action, the Chamber cautioned that escalating pressures across the pharmaceutical supply chain are severely jeopardizing the country’s ability to ensure "uninterrupted access to essential and life saving medicines". The SLCPI stressed that the looming crisis has transcended the boundaries of a sectoral challenge to become a critical national emergency. "It is now a national issue with direct implications for public health, continuity of care, and the country’s ability to respond to everyday and emergency medical needs," the Chamber emphasized.

According to the Chamber, maintaining the regular availability of treatments has become exceedingly difficult due to a combination of rising global supply chain costs, exchange rate volatility, soaring freight and fuel expenses, and escalating clearance costs. Sri Lanka's heavy reliance on imported pharmaceuticals and raw materials leaves the nation acutely vulnerable to global volatility and domestic delays. Stressing that medicines are not ordinary products, the SLCPI noted that their availability depends on a "highly regulated and carefully managed supply chain". From sourcing and quality assurance to secure transportation and timely import clearance, every stage plays a vital role in ensuring safe treatments reach patients.

Over recent months, this intricate system has faced mounting economic pressures. Fuel prices have jumped by around 38 percent, with the possibility of further increases still ahead. Concurrently, freight charges have spiked by over 40 percent, while the global prices of active pharmaceutical ingredients, packaging materials, and solvents have climbed sharply, surging by up to 70 percent in certain cases. Furthermore, the depreciation of the Sri Lankan Rupee against the US Dollar has significantly driven up import costs, intensifying the financial burden across the board. These economic challenges are severely compounded by administrative bottlenecks, specifically delays in the current import licence renewal and pricing review processes.

In a market like Sri Lanka, where order volumes are relatively small, continuous supply relies heavily on timely approvals and predictable systems. When medicines are stalled in the system, suppliers face compounding difficulties in placing orders and clearing consignments, meaning even brief administrative delays can rapidly turn into stock limitations and wider disruptions. Highlighting the gravity of the situation, the Chamber warned: “This is no longer just an industry issue. It is an issue of national preparedness and continuity of care. If urgent steps are not taken now, the country risks moving into a situation where medicine shortages become harder to avoid and even harder to recover from”.

The potential fallout of this supply chain strain is severe, with the Chamber warning that the consequences of inaction will be felt far beyond the industry itself. Patients face the grim prospect of delayed treatments and immense difficulty in accessing vital medications. Hospitals and pharmacies will come under increasing pressure as supply becomes less reliable, potentially forcing doctors to make difficult decisions in the face of limited availability. The SLCPI also cautioned that sustained pressure on the legitimate supply chain can create space for "unauthorised and illegal channels to enter the market". This severely heightens the risk of "substandard or falsified medicines reaching the public," thereby endangering patient health and undermining confidence in the healthcare system.

To stabilize the situation, the SLCPI has urgently requested authorities to take immediate and practical measures to strengthen the systems that keep medicines moving. These recommendations include addressing delays in import licence processing, improving sequencing between import licence renewals and price reviews, and recognizing the sharp escalation in operating and input-related costs. “Sri Lanka must act now to prevent a medicine shortage crisis. The cost of inaction will be felt in delayed treatment, reduced availability, and growing pressure on patients, pharmacies, hospitals, and the wider healthcare system,” the Chamber added. The SLCPI reiterated its commitment to working constructively with regulators to support solutions before today’s strain becomes tomorrow’s national shortage.